CHP investigates probable case of botulism
The Centre for Health Protection (CHP) of the Department of Health (DH) is today (November 12) investigating a probable case of botulism after a patient received injections of botulinum toxin on the Mainland. The CHP again reminded the public that botulinum toxin injections should only be prescribed and performed by registered doctors.
The case involves a female patient aged 38 with good past health. According to information provided by the patient, she received injections that were claimed to be botulinum toxin from a person at a premises in Dongguan on October 27. However, the patient was unable to confirm the professional qualifications of the person who performed the injections. She has presented with symptoms including limbs weakness, swallowing difficulty and bilateral partial ptosis since October 29. She attended a hospital in Dongguan on November 3 and was admitted the same day. The patient attended the North District Hospital on November 8 due to persistent symptoms and was admitted the same day. She is still hospitalised and is in stable condition. She was clinically suspected to have botulism caused by botulinum toxin injection.
The CHP has reported the case to the relevant authority on the Mainland. Epidemiological investigations are ongoing.
"In Hong Kong, botulinum toxin injections should only be performed by a locally registered doctor. Customers should verify the doctor's full name against thelist of registered doctorsof the Medical Council of Hong Kong as well as their professional qualifications and relevant experience. When receiving injections outside Hong Kong, pay special attention to ensure the provider is qualified or registered with relevant jurisdictions for practice. In case of injections offered from suspicious sources, refrain from receiving them. If feeling unwell, seek medical advice from eligible medical professionals as soon as possible," a spokesman for the DH said.
Due to the weakening of associated muscles and the fact that botulinum toxin may spread and affect other areas beyond the injection site, affected patients may have drooping eyelids, double or blurred vision, problems with chewing, hoarseness, or even difficulties in swallowing, speaking or breathing, which may happen hours, days or weeks after the injection.
The DH urged the public to observe the health advice below before receiving botulinum toxin injections:
Injections in Hong Kong should only be performed by locally registered doctors;
Understand the procedure, potential risks and complications before receiving injections. Consult a doctor for an informed decision;
Do not receive injectionsfrom suspicious sources;
Do not receive an injection in the case of a history of allergy tobotulinum toxin, or if there is an infection or inflammation on the injection site;
Request the full name of the doctor in writing if referred by a beauty service provider for the procedure, as well as the professional qualifications and relevant experience; and
If symptoms develop, such as a fever or feeling unwell, seek medical attention immediately.
The public may visit the DH's webpage on thedifferentiation between medical procedures and beauty services, theDrug Databaseof the Drug Office and the CHP'sbotulism pagefor more information.
Remarks by FS at media session (with photo/video)
The Financial Secretary, Mr Paul Chan; the Secretary for Financial Services and the Treasury, Mr Christopher Hui, and the Secretary for Commerce and Economic Development, Mr Algernon Yau, together with the Chief Executive Officer of the Securities and Futures Commission, Ms Julia Leung, and the Chief Executive of the Hong Kong Monetary Authority, Mr Eddie Yue, met the media this evening (April 7). Following are Mr Chan's remarks at the media session:
Reporter: What tools does the Government have to handle the situation of the market and will Hong Kong consider a national team investor equivalent to intervene? Should the markets keep dropping, what is the bottom line for the state of the market before countermeasures will be considered?
Financial Secretary: I think Julia has explained very clearly the situation in the Hong Kong stock market. Basically, the market has been functioning orderly. There are substantial selling but also buying interests. The spread between the two has been very tight, indicating that the buying power remains very strong.
Hong Kong is a free port, and we encourage capital and investors from different parts of the world to take part in our capital market. Over the years, we have been taking a number of measures to enhance the competitiveness and attractiveness of our capital market, no matter whether it is improving the listing regime, lowering the transaction costs, expanding the markets, attracting investors and capital from around the world, or offering new products such as the ETF (exchange-traded fund) listed on the Saudi stock exchange (and investing in the Hong Kong stock market). All in all, we will persistently and consistently push forward initiatives on various fronts. With an expanding market and more participants from different parts of the world, the liquidity and resilience of our market will be enhanced. The resilience of our market has been very strong. We do not think the current volatility in the market warrants the taking of any drastic measures.
(Please also refer to the Chinese portion of the remarks.)
Remarks by FS at media session (with photo/video) Source: HKSAR Government Press Releases
